Please use this identifier to cite or link to this item:
Title: Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article
Authors: Makuku, Rangarirai
Seyedmirzaei, Homa
Tantuoyir, Marcarious M
Rodríguez-Román, Eduardo
Albahash, Assil
Mohamed, Kawthar
Moyo, Ernest
Ahmed, Abdulrazaq Olamilekan
Razi, Sepideh
Rezaei, Nima
Keywords: ART immunotherapy
People living with HIV
CAR T cell therapy
Issue Date: 1-Feb-2022
Publisher: Elsevier
Series/Report no.: International Immunopharmacology;Vol. 105, 108580
Abstract: According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), as of 2019, approximately 42.2 million people have died from acquired immunodeficiency syndrome (AIDS)-related illnesses since the start of the epidemic. Antiretroviral therapy (ART) has significantly reduced mortality, morbidity, and incidence of the human immunodeficiency virus (HIV)/AIDS-defining cancers, taming once-dreaded disease into a benign chronic infection. Although the treatment has prolonged the patients’ survival, general HIV prevalence has increased and this increase has dovetailed with an increasing incidence of Non-AIDS-defining cancers (NADCs) among people living with HIV (PLWH). This is happening when new promising approaches in both oncology and HIV infection are being developed. This review focuses on recent progress witnessed in immunotherapy approaches against HIV-related, Non-AIDS-defining cancers (NADCs), and HIV infection
ISSN: 1567-5769
Appears in Collections:Research Papers

Files in This Item:
File Description SizeFormat 
EXPLORING THE APPLICATION.pdfFull-text729.92 kBAdobe PDFView/Open
Show full item record

Page view(s)

checked on Jul 23, 2024

Google ScholarTM


Items in MSUIR are protected by copyright, with all rights reserved, unless otherwise indicated.